BG Medicine Announces One-for-Four Reverse Stock Split
July 08, 2015 17:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., July 8, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, today announced the effectiveness of a one-for-four reverse stock...
First Automated Test for Galectin-3 Now Available in U.S.
July 06, 2015 08:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., July 6, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, today announced that the ARCHITECT® Galectin-3 assay is now...
BG Medicine Reports First Quarter 2015 Financial Results
May 14, 2015 07:45 ET
|
BG Medicine, Inc.
Net Loss Reduced by 38% and Operating Cash Burn Cut by 42% from First Quarter 2014
Outlook Improved for 2015
WALTHAM, Mass., May 14, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the...
BG Medicine Announces Q1 2015 Financial Results Release Date and Conference Call Information
May 07, 2015 17:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., May 7, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Thursday, May 14, 2015 at 8:30 a.m. Eastern...
BG Medicine Submits 510(k) to FDA for Additional Indication for the BGM Galectin-3(R) Test
March 31, 2015 07:15 ET
|
BG Medicine, Inc.
WALTHAM, Mass., March 31, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, today reported that it has filed a 510(k) Premarket Notification...
BG Medicine Reports 2014 Fourth Quarter and Year End Financial Results
March 31, 2015 07:00 ET
|
BG Medicine, Inc.
Net Loss Reduced by 49% and Operating Cash Burn Cut by 47% From 2013
First Automated Galectin-3 Testing Expected to Launch in U.S. in Mid-2015
WALTHAM, Mass., March 31, 2015 (GLOBE NEWSWIRE) --...
BG Medicine Welcomes Major Publication on the BioImage Study in the Journal of the American College of Cardiology
March 26, 2015 07:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., March 26, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today the publication of a landmark study, in the Journal of the American College of Cardiology, reporting...
BG Medicine Announces Fiscal Year 2014 Financial Results Release Date and Conference Call Information
March 24, 2015 16:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., March 24, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Tuesday, March 31, 2015 at 8:30 am...
BG Medicine Announces Receipt of NASDAQ Notice of Non-Compliance; Intends to Request Hearing and Seek Extension
March 13, 2015 17:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., March 13, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) (the "Company"), the developer of the BGM Galectin-3® Test, today announced its receipt of a notice of...
BG Medicine Announces Receipt of Favorable NASDAQ Listing Determination
February 02, 2015 07:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Feb. 2, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, announced today its receipt of a favorable decision from the Listing...